Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 228

1.

Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently.

Saxena S, Brody AL, Ho ML, Alborzian S, Ho MK, Maidment KM, Huang SC, Wu HM, Au SC, Baxter LR Jr.

Biol Psychiatry. 2001 Aug 1;50(3):159-70.

PMID:
11513814
[PubMed - indexed for MEDLINE]
2.

Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, Ho MK, Huang SC, Wu HM, Baxter LR Jr.

Arch Gen Psychiatry. 2002 Mar;59(3):250-61.

PMID:
11879163
[PubMed - indexed for MEDLINE]
3.

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.

Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR Jr.

Am J Psychiatry. 2003 Mar;160(3):522-32.

PMID:
12611834
[PubMed - indexed for MEDLINE]
4.

Cerebral glucose metabolism in obsessive-compulsive hoarding.

Saxena S, Brody AL, Maidment KM, Smith EC, Zohrabi N, Katz E, Baker SK, Baxter LR Jr.

Am J Psychiatry. 2004 Jun;161(6):1038-48.

PMID:
15169692
[PubMed - indexed for MEDLINE]
5.

Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.

Smith EA, Russell A, Lorch E, Banerjee SP, Rose M, Ivey J, Bhandari R, Moore GJ, Rosenberg DR.

Biol Psychiatry. 2003 Dec 15;54(12):1399-405.

PMID:
14675804
[PubMed - indexed for MEDLINE]
6.

Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings.

Brody AL, Saxena S, Stoessel P, Gillies LA, Fairbanks LA, Alborzian S, Phelps ME, Huang SC, Wu HM, Ho ML, Ho MK, Au SC, Maidment K, Baxter LR Jr.

Arch Gen Psychiatry. 2001 Jul;58(7):631-40.

PMID:
11448368
[PubMed - indexed for MEDLINE]
7.

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls.

Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE.

Arch Gen Psychiatry. 1987 Mar;44(3):211-8. Erratum in: Arch Gen Psychiatry 1987 Sep;44(9):800.

PMID:
3493749
[PubMed - indexed for MEDLINE]
8.

Normal caudate nucleus in obsessive-compulsive disorder assessed by quantitative neuroimaging.

Aylward EH, Harris GJ, Hoehn-Saric R, Barta PE, Machlin SR, Pearlson GD.

Arch Gen Psychiatry. 1996 Jul;53(7):577-84. Review.

PMID:
8660124
[PubMed - indexed for MEDLINE]
9.

Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder.

Kwon JS, Kim JJ, Lee DW, Lee JS, Lee DS, Kim MS, Lyoo IK, Cho MJ, Lee MC.

Psychiatry Res. 2003 Jan 20;122(1):37-47.

PMID:
12589881
[PubMed - indexed for MEDLINE]
10.

Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder.

Remijnse PL, Nielen MM, van Balkom AJ, Hendriks GJ, Hoogendijk WJ, Uylings HB, Veltman DJ.

Psychol Med. 2009 Sep;39(9):1503-18. doi: 10.1017/S0033291708005072. Epub 2009 Jan 27.

PMID:
19171077
[PubMed - indexed for MEDLINE]
11.

Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.

Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME.

Arch Gen Psychiatry. 1996 Feb;53(2):109-13.

PMID:
8629886
[PubMed - indexed for MEDLINE]
12.

Factors associated with major depressive disorder occurring after the onset of obsessive-compulsive disorder.

Besiroglu L, Uguz F, Saglam M, Agargun MY, Cilli AS.

J Affect Disord. 2007 Sep;102(1-3):73-9. Epub 2007 Jan 11.

PMID:
17222458
[PubMed - indexed for MEDLINE]
13.

The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study.

Hansen ES, Hasselbalch S, Law I, Bolwig TG.

Int J Neuropsychopharmacol. 2002 Mar;5(1):1-10.

PMID:
12057027
[PubMed - indexed for MEDLINE]
14.

Reduction of prefrontal cortex glucose metabolism common to three types of depression.

Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM.

Arch Gen Psychiatry. 1989 Mar;46(3):243-50.

PMID:
2784046
[PubMed - indexed for MEDLINE]
15.

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy.

Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, Rapoport SI, Rapoport JL, Grady CL.

Arch Gen Psychiatry. 1992 Sep;49(9):690-4.

PMID:
1514873
[PubMed - indexed for MEDLINE]
16.

Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder.

Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S, Phelps ME, Baxter LR Jr.

Neuropsychopharmacology. 1999 Dec;21(6):683-93.

PMID:
10633474
[PubMed - indexed for MEDLINE]
Free Article
17.

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.

Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS, Manji HK, Drevets WC.

Biol Psychiatry. 2007 Oct 15;62(8):870-7. Epub 2007 Aug 2.

PMID:
17678634
[PubMed - indexed for MEDLINE]
18.

Brain structural correlates of depressive comorbidity in obsessive-compulsive disorder.

Cardoner N, Soriano-Mas C, Pujol J, Alonso P, Harrison BJ, Deus J, Hernández-Ribas R, Menchón JM, Vallejo J.

Neuroimage. 2007 Nov 15;38(3):413-21. Epub 2007 Aug 11.

PMID:
17889563
[PubMed - indexed for MEDLINE]
19.

Regional cerebral glucose metabolism in bulimia nervosa.

Andreason PJ, Altemus M, Zametkin AJ, King AC, Lucinio J, Cohen RM.

Am J Psychiatry. 1992 Nov;149(11):1506-13. Erratum in: Am J Psychiatry 1993 Jan;150(1):174.

PMID:
1415817
[PubMed - indexed for MEDLINE]
20.

Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder.

Rauch SL, Dougherty DD, Cosgrove GR, Cassem EH, Alpert NM, Price BH, Nierenberg AA, Mayberg HS, Baer L, Jenike MA, Fischman AJ.

Biol Psychiatry. 2001 Nov 1;50(9):659-67.

PMID:
11704072
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk